Antibiotic resistance in gram-negative peritonitis

Peritoneal Dialysis International

Volumn 29, Issue 3, 2009, Pages 274-276

  Borràs, Mercè ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CATHETER INFECTION; CATHETER REMOVAL; CONTAMINATION; DRUG EFFICACY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXIT SITE INFECTION; GRAM NEGATIVE INFECTION; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NOTE; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR;

EID: 67649304494     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900309     Document Type: Note

References (24)

1. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Continuous peritoneal dialysis associated peritonitis: a review and current concepts. Semin Dial 2003; 16:428-37.
2. Burkart JM, Hylander B, Durnell-Figel T, Roberts D. Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10:41-3.
3. Tielens E, Nubé MJ, de Vet JA, van Limbeek J, Hofman X, Steffens A, et al. Major reduction of CAPD peritonitis after the introduction of the twin-bag system. Nephrol Dial Transplant 1993; 8:1237-43.
4. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24:424-32.
5. Szeto CC, Leung CB, Chow KM, Kwan BC, Law MC, Wang AY, et al. Change in bacterial aetiology of peritoneal-dialysis-related peritonitis over ten years: experience from a center in South-East Asia. Clin Microbiol Infect 2005; 10:837-9.
6. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36:1009-13.
7. Bunke CM, Briel MR, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52:524-9.
8. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
9. Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int 2001; 59:2309-15.
10. Szeto CC, Chow VY, Chow KM, Lai RM, Chung KY, Leung CB, et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69:1245-52.
11. Valdés-Sotomayor J, Cirugeda A, Bajo MA, del Peso G, Escudero E, Sánchez-Tomero JA, et al. Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit Dial Int 2003; 23:450-5.
12. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs 1999; 57:81-91.
13. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000; 49:827-30.
14. Pérez Fontan M, Lueiro F. Escherichia coli peritonitis in patients undergoing peritoneal dialysis: a serious problem that may get worse. Perit Dial Int 2006; 26:174-7.
15. Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, et al. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis 2008; 51:455-62.
16. Bernardini J, Bender F, Florio T, Sloand J, PalmMontalbano L, Fried L, et al. Randomized double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-45.
17. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lapin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995; 49:711-45.
18. Ceri H, Olson ME, Morck DW, Storey D, Read RR, Buret AG. The MBEC assay system: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 2001; 337:377-85.
19. Sepandj F, Ceru H, Gibb A, Read R, Olson M. Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis. Perit Dial Int 2004; 24:65-7.
20. Barretti P, Pereira D, Brasil MA, de Lourdes Cunha M, Caramori J, Montelli A. Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center's experience over nine years. Perit Dial Int 2009; 29:230-3.
21. Keithi-Reddy SR, Gupta KL, Jha V, Sud K, Singh SK, Kohli HS, et al. Spectrum and sensitivity pattern of gram-negative organisms causing CAPD peritonitis in India. Perit Dial Int 2007; 27:205-7.
22. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
23. Yip T, Tse KC, Lam MF, Tang S, Li FK, Choy BY, et al. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int 2006; 26:191-7.
24. Szeto CC, Chow KM. Gram-negative peritonitis - the Achilles heel of peritoneal dialysis? Perit Dial Int 2007; 27(Suppl 2):S267-71.